SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Deals
Alexion, BioMarin, Sanofi, Shire May Be Eyeing Dyax Corp. and Its Rare Genetic Disorder Drug
June 11, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
FDA
FDA Advisors Back Regeneron, Sanofi’s New Heart Drug With Limits
June 10, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Pharm Country
Regeneron Trading Halted While FDA Considers New Drug Developed With Sanofi
June 9, 2015
 · 
3 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Business
Former Sanofi Exec and Viehbacher Protoge to Join Alnylam as Senior VP
June 8, 2015
 · 
3 min read
Business
Ex-Obama and Clinton Foundation Official to Head Sanofi External Affairs
June 3, 2015
 · 
3 min read
Deals
Ousted Sanofi Exec’s New Company Aims For $160 Million London IPO
May 26, 2015
 · 
4 min read
Business
Another Top Sanofi Exec Resigns, As Purging of Old Guard Continues
May 26, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Biotech Beach
Amgen Beats Sanofi to Market with EU Hurdle for Anti-Cholesterol Drug
May 22, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Regeneron and Sanofi Partnership Records Another Hit In Latest String of Successes
May 21, 2015
 · 
4 min read
Load More
JOBS
IN THE PRESS
Pharm Country
Regeneron, Sanofi’s Big New Cholesterol Drug Praluent Wins European Green Light
July 24, 2015
 · 
9 min read
Drug Development
Regeneron And Sanofi Announce Phase III Results Showing LDL-C Reductions Of More Than 60 Percent In Japanese Patients Treated With Praluent(Alirocumab) Injection
July 9, 2015
 · 
10 min read
Consumer Watchdog Asks FDA to Revoke Approval of Sanofi’s Seprafilm
July 8, 2015
 · 
1 min read
Business
Ex-Sanofi Exec to Head Teva UK
June 16, 2015
 · 
1 min read
Drug Development
Zealand Pharma Informs Of Updates Given By Sanofi On Lyxumia And Lixilan On An IR Thematic Conference Call On Diabetes
June 9, 2015
 · 
3 min read
Drug Development
Sanofi’s Lyxumia (lixisenatide) Demonstrated Cardiovascular Safety In People With Type 2 Diabetes And High CV Risk
June 8, 2015
 · 
8 min read
Pharm Country
Sanofi Release: Sarilumab EULAR 2015 Presentations
June 8, 2015
 · 
1 min read
Drug Development
Zealand Pharma Announces That Sanofi Has Informed Of Results From Getgoal Duo-2, Showing Advantages Of Lyxumia Versus Rapid-Acting Insulin As Add-On To Lantus For The Treatment Of Type 2 Diabete
June 8, 2015
 · 
6 min read
Policy
FDA Staff Says Regeneron, Sanofi Drug Cuts Cholesterol But Questions Benefits
June 8, 2015
 · 
1 min read
Drug Development
Sanofi Announces Study Program Evaluating Toujeo In A Real-Life Setting
June 4, 2015
 · 
8 min read
Load More